$Virax Biolabs (VRAX.US)$
Shares of nano-cap diagnostics company Virax Biolabs Group (NASDAQ:VRAX) more than doubled in value in the morning hours Thursday as the company drew Wall Street's attention amid a rising number of bird flu cases worldwide.
Several countries, including the U.S., have already reported human bird flu infections as the highly pathogenic avian influenza virus, including its H5N1 form, continues to spread in poultry and cattle.

$Regulus Therapeutics (RGLS.US)$Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity at $1.60
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into a definitive securities purchase agreement in connection with a private placement to certain institutio...

$Safe & Green Development (SGD.US)$ sell?

$CERo Therapeutics (CERO.US)$ Cannot fly